Anthony Young Evip

*NO COLD PITCHING - Serial Entrepreneur / Angel / VC / Private Equity / Early Stage Investor / Biotech / Proptech / Space / Aerospace & Defense / Sports / Hospitality

📍 United States, United States🔄 Updated September 2026💼 32 investments📅 10 years investing🗓 Last invested Jul 2026
VC🌍 United States20+ investmentsInvested this quarter
32
Total investments
4
Early stage
7
Mid stage
11
Late stage
10y
Years active

Portfolio

25 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor / Shareholder
Jul 2026
Graphene is about to change our world. Graphene is vastly more important to the 21st Century than plastics were to the 20th Century. Graphene is the megatrend of the 21st Century. Many leading tech companies and numerous startups are poised to enhance hundreds of products with graphene. ‘Flakes’ are industry’s preferred form factor of graphene. However, mass production of graphene-enabled products is held back because there is no known technology to produce industrial quantities of reasonably priced very high-quality graphene flakes. Explosive growth in demand for graphene flakes is expected as soon as industrial quantities of very high-quality graphene become available at reasonable price. Avadain has successfully demonstrated a breakthrough, globally patented and green manufacturing process to produce large, thin and nearly defect free graphene flakes at low cost. We need to upscale to high-throughput production lines. We have the team, including strong partners, to achieve continuous production. Avadain has a capital-light licensing model to democratize graphene. Based on our highly differentiated technology and global patent portfolio, we plan to license our graphene flake manufacturing process to (1) advanced materials manufacturing companies, (2) graphene applications companies and (3) end users which need to assure quality and reliability of supply. Avadain’s mission is to unleash the Graphene Revolution. Our goal is that our flakes will touch the lives of most people every day, making the world a cleaner, better place.
Investor / Shareholder
May 2026
Rejuvenate Bio is targeting the core drivers of chronic age-related diseases by unlocking the power of gene expression and epigenetic reprogramming to reverse pre-existing heart disease, metabolic disease, and kidney failure in humans.
Investor / Shareholder
Mar 2026
We are building something no one else has, the worlds first Atari Hotel, in downtown Phoenix. Atari Hotels is an entertainment destination like no other with gaming, music, a sports book, restaurants & bars… an immersive experience throughout. We own an incredible piece of land in downtown Phoenix at the Intersection of Roosevelt and Central, which is appraised at $14M. We are currently raising an additional $40M via a Reg A+ offering (crowdfunding), for as little as $500 you can invest alongside us. Follow us and get an inside look as we bring the world’s first Atari Hotel to life. Step inside a world where nostalgia meets next generation. Working with Intel to bring a game-changing experience. Imagine yourself in a 2,000+ person arena, surrounded by the energy of live concerts, or esports showdown. Cheer on your favorite team in our state-of-the-art sportsbook, or dive into incredible food and drinks at our signature restaurants and bars. Every corner, every moment, every stay… Atari Hotels, an immersive experience like no other.
late stageHospitality
Investor / Shareholder
Nov 2025
At Vertical Longevity Pharma, were harnessing the power of virus-like particle (VLP) vaccines to eliminate senescent cells, one of the fundamental drivers of aging and chronic disease. Preclinical senescent cell clearance has demonstrated therapeutic benefits across every organ system investigated, including curative potential for atherosclerosis, the world’s leading cause of death. Engineered for stability at room temperature, our immunotherapy can remove the need for cold-chain logistics, enabling global accessibility and scalability even in low-resource settings. If you share our vision for extending healthy human lifespan or have a personal connection to heart disease, you can now become part of this mission. Low barrier to entry and no investor accreditation required: 👉 https://netcapital.com/companies/vertical-longevity
Investor / Shareholder
Oct 2025
An elevated flying experience.
Investor / Shareholder
Sep 2025
CancerVax is a pre-clinical biotech company developing a novel Universal Cancer Treatment Platform that will be customizable as an injection, to treat many types of cancer. Powered by artificial intelligence, our revolutionary approach DETECTS, MARKS, and KILLS only cancer cells using the body’s own immune system. Other immunotherapies have had very limited success trying to teach the immune system how to recognize cancer cells. Instead, we intend to make cancer cells look like a common disease that it already recognizes, such as measles, and “trick” the body into killing these “disguised” cancer cells with strength. We look forward to the day when treating cancer will be as simple as getting a shot.
Investor / Shareholder
Sep 2025
Doroni Aerospace is transforming urban transportation with innovative electric vertical takeoff and landing (eVTOL) technology. Founded in 2017, our mission is to elevate the way people connect with the world around them by offering sustainable, efficient, and immersive travel experiences. Our H1-X model embodies our commitment to cutting-edge innovation, safety, and accessibility. Join us in shaping the future of urban mobility.
Investor / Shareholder
Aug 2025
Above: Space Development Corporation is a space development company providing rapid and low cost Hybrid-Gravity™ space platforms for manufacturing, data processing, R&D, tourism, and more. #SpaceIsForEveryone #WeProvideGravity
Investor / Shareholder
May 2025
The fight against cancer needs new, big, bold ideas. At Siren, we’ve got one: Universal AAV Immuno-Gene Therapy. We are combining two transformative therapeutic technologies – AAV gene therapy and cytokine immunotherapy - into a single, reimagined modality that overcomes key challenges and redefines how we destroy tumor cells and elicit anti-tumor immunity.
Strategic Advisor / Shareholder
Apr 2025
Our mission is to help parents and caregivers raise Real MVPs through multifaceted, purposeful entertainment and resources. Everything we create is with the intention of inspiring a childs character. Our vision is to create a World of MVP Kids, integrating all types of childrens media and entertainment to engage kids of all ages, including: - Fun and purposeful television and video streaming content - Engaging and resource rich publishing, bridging child/mentor conversations - Education focused school and homeschool curriculum - Interactive, literacy nurturing apps - Interactive fun and purposeful games. Visit us at MVPKids.com or on Facebook and Instagram at Real MVP Kids. For schools and educators, our curriculum distributor is Becker School Supplies, www.shopbecker.com.
Investor / Shareholder
Apr 2025
At LifeBridge Innovations, PBC, oue mission is to transform Metastatic Cancer from a terminal prognosis in to a manageable disease like diabetes - using our patented Adaptive Tumor Treating Field (ATTF) therapy. We believe that ATTF has the potential to become the standard of care for Metastatic Disease in the torso within 5 years of commercial availability. We are currently preparing for animal safety trials and and have a fully FDA vetted clinical protocol for our Human Pilot Clinical Trial. In fact, the FDA granted us Basket Trial status so that we can include up to 14 different types of cancer in a single clinical study. This is a first for any TTF-based trial.
Investor / Shareholder
Apr 2025
#WestchesterCounty is #SoccerCounty! We are Westchester’s homegrown USL League One professional soccer team, kicking off March 2025 from the Stadium at Memorial Field. Were starting with a USL League One men’s professional team for the 2025 season and will look to bring a professional women’s team in the coming years. Together with our passionate local soccer community, our aim is to become the cornerstone of Westchester’s already thriving soccer ecosystem and ascend to the highest tier of the USL’s professional soccer pyramid. We are committed to building both world-class boys’ and girls’ developmental pipeline for Westchester’s incredible local player base. Become a supporter today and join the Westchester SC team from launch.
Investor / Shareholder
Mar 2025
The Horror Section is a media company focused on creating the world’s premier genre brand. Founded by horror film legend Eli Roth in partnership with Media Capital Technologies (MCT), the company super-serves horror fans by owning and controlling a premium intellectual property library of unhinged films, television series, and games, in addition to a podcast and curating horror-centric experiences.
Founding Investor / Shareholder
Dec 2024
Ecuatoriana Airlines, la nueva aerolínea en Ecuador.
Investor / Shareholder
Sep 2024
StartEngine is one of the leading equity crowdfunding platforms in the U.S., where everyday people can find and invest in early-growth companies and startups, as well as a variety of alternative assets and collectibles. StartEngine has hosted over 1,100 successful funding rounds between Reg. CF and Reg. A+ combined through StartEngine’s funding portal and broker dealer, from a community of over 1,000,000 strong. Based in Los Angeles, the company was created in 2014 by Howard Marks, co-founder of Activision, and Ron Miller. Were hiring: https://www.startengine.com/careers Invest in startups and build your portfolio. www.startengine.com For accredited investors – exclusive investment opportunities from some of todays largest privately held companies. www.startengine.com/private **“StartEngine" refers to StartEngine Crowdfunding, Inc. StartEngine operates 5 wholly owned subsidiaries, StartEngine Capital, LLC, StartEngine Primary, LLC, StartEngine Secure, LLC, StartEngine Private LLC, and StartEngine Assets, LLC. Unless otherwise indicated, Regulation Crowdfunding offerings are offered through StartEngine Capital LLC, an SEC-registered funding portal and FINRA member; brokerage services, including Regulation A+ and Regulation D offerings, brokerage accounts, and securities trading through StartEngine Secondary (a SEC-regulated alternative trading system, operated by StartEngine Primary, LLC), are offered through StartEngine Primary, LLC, a broker-dealer registered with the SEC and FINRA/SIPC; and transfer agent services are offered through StartEngine Secure, LLC, an SEC registered transfer agent. StartEngine Assets LLC is an asset manager for StartEngine Collectibles Fund I LLC which offers Regulation A+ offerings in collectibles (e.g., fine art, wine) through the StartEngine platform.
Show all 25 investments ↓
Experience · 45 entries
All (45)
Investments (30)
Founder (9)
2026
Investor / Shareholder
Jul 2026
Graphene is about to change our world. Graphene is vastly more important to the 21st Century than plastics were to the 20th Century. Graphene is the megatrend of the 21st Century. Many leading tech companies and numerous startups are poised to enhance hundreds of products with graphene. ‘Flakes’ are industry’s preferred form factor of graphene. However, mass production of graphene-enabled products is held back because there is no known technology to produce industrial quantities of reasonably priced very high-quality graphene flakes. Explosive growth in demand for graphene flakes is expected as soon as industrial quantities of very high-quality graphene become available at reasonable price. Avadain has successfully demonstrated a breakthrough, globally patented and green manufacturing process to produce large, thin and nearly defect free graphene flakes at low cost. We need to upscale to high-throughput production lines. We have the team, including strong partners, to achieve continuous production. Avadain has a capital-light licensing model to democratize graphene. Based on our highly differentiated technology and global patent portfolio, we plan to license our graphene flake manufacturing process to (1) advanced materials manufacturing companies, (2) graphene applications companies and (3) end users which need to assure quality and reliability of supply. Avadain’s mission is to unleash the Graphene Revolution. Our goal is that our flakes will touch the lives of most people every day, making the world a cleaner, better place.
Investor / Shareholder
May 2026
Rejuvenate Bio is targeting the core drivers of chronic age-related diseases by unlocking the power of gene expression and epigenetic reprogramming to reverse pre-existing heart disease, metabolic disease, and kidney failure in humans.
Investor / Shareholder
Mar 2026
We are building something no one else has, the worlds first Atari Hotel, in downtown Phoenix. Atari Hotels is an entertainment destination like no other with gaming, music, a sports book, restaurants & bars… an immersive experience throughout. We own an incredible piece of land in downtown Phoenix at the Intersection of Roosevelt and Central, which is appraised at $14M. We are currently raising an additional $40M via a Reg A+ offering (crowdfunding), for as little as $500 you can invest alongside us. Follow us and get an inside look as we bring the world’s first Atari Hotel to life. Step inside a world where nostalgia meets next generation. Working with Intel to bring a game-changing experience. Imagine yourself in a 2,000+ person arena, surrounded by the energy of live concerts, or esports showdown. Cheer on your favorite team in our state-of-the-art sportsbook, or dive into incredible food and drinks at our signature restaurants and bars. Every corner, every moment, every stay… Atari Hotels, an immersive experience like no other.
late stageHospitality
Jury Member
Jan 2026
Global Startup Award. We evolve the culture with which the Venture Capital industry began. Based on trust, fast decision-making, and outstanding results.
2025
Syndicate Partner
Dec 2025
Unicorner is the newsletter that delivers a 2 minute rundown of an up-and-coming startup to your inbox every Monday morning.
Show all 45 entries ↓
Investment activity
2016–2026 · 32 investments
20161201722018120191202112023120241020251220263
Recent (last 2 years)Earlier